Stay updated on Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's related topics/MeSH metadata no longer lists Melanoma and MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2026-06-20T22:15:34.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page adds recruitment status text ('No longer looking for participants'), introduces new help and navigation sections, and updates the revision label, while a heading formatting change standardizes 'Intervention/Treatment'.
    Difference
    0.6%
    Check dated 2026-06-13T17:47:33.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.5.5 and some related topics and an older revision tag were removed, indicating a minor metadata cleanup.
    Difference
    0.2%
    Check dated 2026-06-06T14:19:04.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now includes additional related topics and links: Melanoma and MedlinePlus Genetics. These additions provide extra context without altering the study details.
    Difference
    0.2%
    Check dated 2026-05-30T12:34:05.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Removed items from the related resources block, including the Melanoma entry, the 'related topics:' header, and the MedlinePlus Genetics link.
    Difference
    0.2%
    Check dated 2026-05-23T09:26:56.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Melanoma is added as a related topic and MedlinePlus Genetics is listed under related topics, and the page revision has been updated from v3.5.3 to v3.5.4.
    Difference
    0.2%
    Check dated 2026-05-15T23:19:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.